Compound Detail
CHEMBL5426800
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
CC(C)c1ccc2c(c1)CC[C@H]1[C@](C)(C(=O)OCc3cn(CC4CN(c5ccccc5Cl)C(=O)O4)nn3)CCC[C@]21C
Basic Information
| ChEMBL ID | CHEMBL5426800 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | SGNKWCYZDCITOM-UFPKQXNFSA-N |
5
Targets
5
Activities
1
Assay Types
0
PK Parameters
5
Publications
0
Known Names
Molecular Properties
591.1
MW (Da)
6.83
ALogP
7
HBA
0
HBD
86.5
PSA (Ų)
0.28
QED
2
Ro5 Violations
7
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 5 meas. best 4.96
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| MGC-803 | IC50 | = | 11020.0 | nM | 4.96 | Anticancer activity against human MGC-803 cells assessed as inhibition of cell g... | 38389893 |
| HepG2 | IC50 | = | 13620.0 | nM | 4.87 | Anticancer activity against human HepG2 cells assessed as inhibition of cell gro... | 38389893 |
| HeLa | IC50 | = | 14000.0 | nM | 4.85 | Anticancer activity against human HeLa cells assessed as inhibition of cell grow... | 38389893 |
| L02 | IC50 | = | 21410.0 | nM | 4.67 | Cytotoxicity against human LO2 cells assessed as reduction in cell viability inc... | 38389893 |
| T-24 | IC50 | = | 70400.0 | nM | 4.15 | Anticancer activity against human T-24 cells assessed as inhibition of cell grow... | 38389893 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 38389893 | 10.1039/d3md00550j | HeLa | 1 |
| 38389893 | 10.1039/d3md00550j | HepG2 | 1 |
| 38389893 | 10.1039/d3md00550j | MGC-803 | 1 |
| 38389893 | 10.1039/d3md00550j | T-24 | 1 |
| 38389893 | 10.1039/d3md00550j | L02 | 1 |
Data from ChEMBL 36 via Core Engine